Literature DB >> 92986

Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells.

B Jasani, G Kreil, B F Mackler, D R Stanworth.   

Abstract

Structure-activity studies have been performed on a series of naturally occurring and 'tailor-made' polypeptides, by measurement of ability to induce selective histamine release from normal rat peritoneal mast cells in vitro. Compounds investigated include corticotropin and melittin derivatives, mast-cell-degranulating peptide from bee venom, polymyxin B, bradykinin and various synthetic poly(amino acids) and short-chain peptides. It was confirmed that a cluster of four basic residues (lysine or arginine) was optimal for histamine release by corticotropin and melittin polypeptides, provided that the C-terminal carboxyl group was substituted (by, for instance, amidation). In contrast, the presence of a free C-terminal carboxyl group or nearby dicarboxylic acid residues led to a considerable diminution in histamine-releasing activity. Likewise, polypeptides comprised essentially of acidic amino acids were inactive. On the basis of these observations it has been possible to predict that synthetic peptides comprising a particular sequence within the Fc region of human immunoglobulin E, the immunoglobulin class particularly involved in mediation of allergic reactions of the immediate type, would possess potent histamine-releasing activity when similarly made to react with normal rat mast cells. The further study of such a structure should throw new light on the molecular basis of allergen-antibody triggering of mast cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92986      PMCID: PMC1161201          DOI: 10.1042/bj1810623

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  A new approach to the structure-activity relationship for ACTH analogs using isolated adrenal cortex cells.

Authors:  S Seelig; B D Lindley; G Sayers
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Membrane matrix disruption by melittin.

Authors:  J C Williams; R M Bell
Journal:  Biochim Biophys Acta       Date:  1972-11-02

3.  Polypeptide hormone interaction. II. Glucagon binding to lysolecithin.

Authors:  A B Schneider; H Edelhoch
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

4.  Polypeptide hormone interaction. 3. Conformational changes of glucagon bound to lysolecithin.

Authors:  A B Schneider; H Edelhoch
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

5.  Adenyl cyclase in fat cells. 3. Stimulation by secretin and the effects of trypsin on the receptors for lipolytic hormones.

Authors:  M Rodbell; L Birnbaumer; S L Pohl
Journal:  J Biol Chem       Date:  1970-02-25       Impact factor: 5.157

6.  Synthetic polypeptides related to corticotrophin acting as histamine liberators.

Authors:  R Jaques; M Brugger
Journal:  Pharmacology       Date:  1969       Impact factor: 2.547

7.  Structure-activity relationship of colistins.

Authors:  K Nakajima
Journal:  Chem Pharm Bull (Tokyo)       Date:  1967-08       Impact factor: 1.645

8.  Haemolytic activity and action on the surface tension of aqueous solutions of synthetic melittins and their derivatives.

Authors:  E Schröder; K Lübke; M Lehmann; I Beetz
Journal:  Experientia       Date:  1971-07

9.  Correlation of bradykinin structure with ability to increase vascular permeability.

Authors:  G J Melrose; H K Muller; W J Vagg
Journal:  Nature       Date:  1970-02-07       Impact factor: 49.962

10.  Histamine-releasing effect of a corticotrophin derivative. I. Histamine-releasing effect of a nonadecapeptide in comparison with that of other histamine liberators.

Authors:  M Rüegg; R Jaques
Journal:  Pharmacology       Date:  1977       Impact factor: 2.547

View more
  22 in total

1.  Effect of chemical modifications of myelin basic protein on its interaction with lipid interfaces and cell fusion ability.

Authors:  C G Monferran; B Maggio; F A Cumar
Journal:  Mol Cell Biochem       Date:  1986-05       Impact factor: 3.396

2.  Structural requirements for mast cell triggering by substance P-like peptides.

Authors:  H Repke; M Bienert
Journal:  Agents Actions       Date:  1988-04

Review 3.  Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics.

Authors:  Chiachen Chen; Abner L Notkins; Michael S Lan
Journal:  Mol Cancer Res       Date:  2019-05-21       Impact factor: 5.852

4.  Characteristics of beta-endorphin-induced histamine release from rat serosal mast cells. Comparison with neurotensin, dynorphin and compound 48/80.

Authors:  A Sydbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

5.  The histamine-releasing effect of dynorphin and other peptides possessing Arg-Pro sequences.

Authors:  A Sydbom; L Terenius
Journal:  Agents Actions       Date:  1985-04

Review 6.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

7.  Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor.

Authors:  L A Miller; D E Cochrane; R E Carraway; R S Feldberg
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Effects of human hair and nail proteins and their films on rat mast cells.

Authors:  Toshihiro Fujii; Shinya Murai; Kousaku Ohkawa; Toshihiro Hirai
Journal:  J Mater Sci Mater Med       Date:  2007-12-23       Impact factor: 3.896

9.  Further studies on histamine release from rat mast cells in vitro induced by peptides. Characteristics of a synthetic intermediate with potent releasing activity.

Authors:  P D Roy; D M Moran; V Bryant; R Stevenson; D R Stanworth
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

10.  Pulmonary polyamine permeability factor.

Authors:  J M Gleisner; L M Patt; C A Ramthun; J C Houck
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.